Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia



Status:Completed
Conditions:Pneumonia
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:9/9/2018
Start Date:December 14, 2016
End Date:August 7, 2018

Use our guide to learn which trials are right for you!

A Phase 3, Multicenter, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety and Efficacy of Intravenous to Oral Delafloxacin in Adult Subjects With Community-Acquired Bacterial Pneumonia

The purpose of this study is to evaluate the safety and efficacy of delafloxacin compared to
moxifloxacin in the treatment of adult patients with community-acquired pneumonia.

The purpose of this study is to determine if delafloxacin, an investigational drug, is safe
and effective in the treatment of community-acquired bacterial pneumonia compared with
moxifloxacin, or linezolid in the case of confirmed MRSA.

Inclusion Criteria:

1. Male or female 18 years of age or older

2. Evidence of acute onset of CABP with 2 or more of the following symptoms (new or
worsening)

- Cough

- Production of purulent sputum consistent with bacterial infection

- Difficulty breathing

- Chest pain due to pneumonia

AND have at least 2 of the following findings:

- Fever (oral temperature >38.0°C)

- Hypothermia (oral temperature <35.0°C)

- Tachycardia (heart rate >100 beats/min)

- Tachypnea (respiratory rate >18 breaths/min)

AND have at least 1 of the following findings:

- Hypoxemia (oxygen saturation <90% or PaO2 < 60 mmHg) on room air or with
subject's baseline (pre-CABP under study) supplemental oxygen

- Clinical evidence of pulmonary consolidation and/or presence of pulmonary rales

- An elevated white blood cell count (WBC) >10,000/mm3 or 15% immature neutrophils
(bands), regardless of total peripheral WBC count or leukopenia with WBC
<4500/mm^3

3. Presence of lobar, multilobar, or patchy parenchymal infiltrate(s) consistent with
acute bacterial pneumonia on a pulmonary imaging study within 48 hours before the
first dose of study drug

4. PORT risk class of II to V (PSI score >50)

5. Must be a suitable candidate for possible IV to oral switch antibiotic therapy and
must also be able to swallow large tablets/capsules intact without crushing

Exclusion Criteria:

1. A medical history of significant hypersensitivity or allergic reaction to antibiotics
of the quinolone or oxazolidinone class or study drug excipients according to the
investigator

2. Any infection expected to require other systemic antibiotics in addition to study drug

3. Receipt of systemic antibiotic therapy in the 7 days before enrollment unless 1 of the
following is documented:

- Received at least 48 hours of antibiotic therapy for CABP and clinic notes
document treatment failure (i.e., not by patient history or pulmonary imaging
alone) with new or worsening symptoms while on pre-study therapy

- Received 1 dose of a single, potentially effective, short-acting antibacterial
drug or drug regimen for CABP within 24 hours before enrollment (limited to 25%
of enrolled patients)

4. Respiratory infection confirmed or suspected to be secondary to hospital-acquired or
ventilator-associated pneumonia OR requires treatment in an intensive care setting, OR
requires mechanical ventilation

5. Current or suspected diagnosis of viral, fungal, or aspiration pneumonia,
noninfectious causes of pulmonary infiltrates, lung cancer, cystic fibrosis,
tuberculosis, empyema (not including sterile parapneumonic effusions)

6. Known anatomical or pathological bronchial obstruction OR history of bronchiectasis OR
GOLD Stage 4 COPD OR history of post obstructive pneumonia

7. Severely compromised immune system

8. Known history of Child-Pugh Class B or C liver disease

9. History of post-antibiotic colitis within last 3 months

10. Other exclusions include those described in the safety label for drugs in the
quinolone and/or oxazolidinone classes such as QT prolongation, proarrhythmic
conditions, concomitant use of drugs known to cause QT prolongation, peripheral
neuropathy, tendon disorders, history of myasthenia gravis, liver disease, severe
renal disease, seizures and concomitant use of MAO A or B inhibitor agents and
adrenergic serotonergic agents
We found this trial at
25
sites
Natchitoches, Louisiana 71457
?
mi
from
Natchitoches, LA
Click here to add this to my saved trials
Baltimore, Maryland 21201
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Buenos Aires,
?
mi
from
Buenos Aires,
Click here to add this to my saved trials
Buffalo, New York 14215
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
Burlington, Massachusetts 01805
?
mi
from
Burlington, MA
Click here to add this to my saved trials
Butte, Montana 59701
?
mi
from
Butte, MT
Click here to add this to my saved trials
Charlotte, North Carolina 28203
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cleveland, Ohio 44106
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Coral Gables, Florida 33134
?
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Corsicana, Texas 75110
?
mi
from
Corsicana, TX
Click here to add this to my saved trials
Dayton, Ohio 45402
?
mi
from
Dayton, OH
Click here to add this to my saved trials
DeBary, Florida 32713
?
mi
from
DeBary, FL
Click here to add this to my saved trials
DeLand, Florida 32720
?
mi
from
DeLand, FL
Click here to add this to my saved trials
Fort Myers, Florida 33901
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Franklin, Tennessee 37067
?
mi
from
Franklin, TN
Click here to add this to my saved trials
Louisville, Kentucky 40202
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Miami, Florida 33126
?
mi
from
Miami, FL
Click here to add this to my saved trials
Montgomery, Alabama 36106
?
mi
from
Montgomery, AL
Click here to add this to my saved trials
Newark, Delaware 19718
?
mi
from
Newark, DE
Click here to add this to my saved trials
Newark, New Jersey 07102
?
mi
from
Newark, NJ
Click here to add this to my saved trials
Omaha, Nebraska 68124
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Rapid City, South Dakota 57702
?
mi
from
Rapid City, SD
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Saint Paul, Minnesota 55104
?
mi
from
Saint Paul, MN
Click here to add this to my saved trials